Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL ... Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 42.94 | 6.11628635729 | 702.06 | 745.19 | 672.5 | 927586 | 690.63383282 | CS |
| 4 | 30.55 | 4.2760165162 | 714.45 | 745.19 | 655.85 | 859552 | 690.18283476 | CS |
| 12 | 14.225 | 1.94656357976 | 730.775 | 745.19 | 655.85 | 888852 | 698.67002829 | CS |
| 26 | -399.22 | -34.8901435039 | 1144.22 | 1170.58 | 655.85 | 823137 | 803.4021033 | CS |
| 52 | -226.09 | -23.2820850797 | 971.09 | 1211.1999 | 655.85 | 631483 | 882.48255687 | CS |
| 156 | 128.87 | 20.916040446 | 616.13 | 1211.1999 | 538.01 | 618242 | 791.46938858 | CS |
| 260 | 259.54 | 53.4626951757 | 485.46 | 1211.1999 | 418.01 | 744667 | 673.10785964 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
